Searched for
DOSAGE FORMS
New rules simplify drug launches, reduce manufacturer liability for overchargingNew rules now allow drug manufacturers to launch similar medicines without prior price approval, streamlining market entry. Companies can s...- Drugmakers yet to see gains from government's minimum import price policyGovernment's Minimum Import Price (MIP) initiative to boost domestic drug makers faces a slow start. Despite setting price thresholds for k...
- Zydus Semaglutide approval: Delhi HC directs CDSCO to decide on patient safety concernsThe Delhi High Court has asked the Central Drugs Standard Control Organisation to review a petition challenging Zydus Lifesciences' approva...
- The supplement your doctor hasn't mentioned yet could be quietly fighting type 2 diabetes - here's everything you need to knowFish oil benefits for type 2 diabetes: Fish oil supplementation reduced insulin resistance and improved glucose tolerance in non-obese diab...
- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Holding stocks is harder than finding them: 10 mid- and small-caps stocks that may be worth holding on toHolding a stock is not an act of blind faith. It is not refusing to change one’s mind. It is not averaging down because the stock has falle...
- Drugmakers must report safety data from launch date, not approval date: CDSCOIndia's drug regulator has issued a new directive for pharmaceutical companies. Periodic Safety Update Reports for new drugs must now be su...
- Drug regulator cracks down on delayed safety reporting by pharma companiesIndia's drug regulator CDSCO has issued new rules for drug safety reporting. Companies must now submit safety reports from the actual launc...
- Tooth regeneration therapy enters first human clinical trials in JapanA groundbreaking human trial in Japan is exploring a revolutionary treatment to regrow teeth. Researchers have identified a way to activate...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- After tablets, Hetero working on antiviral medicine Favipiravir injectionsIf successful, Hetero will become the first Indian drug maker to introduce favipiravir in injection form which is hitherto available only i...
- Piramal Pharma Solutions to acquire G&W Laboratories' drug manufacturing facility in USThe site has received certifications from the Food and Drug Administration (FDA) and European Medicines Agency (EMA), it added.
- Strides Shasun rallies nearly 7% as Bangalore plant completes US FDA inspectionShares of Strides Shasun were trading 5.6 per cent higher on the BSE at Rs 1,192. It hit a low of Rs 1,160 and a high of Rs 1,205 in trade ...
- Strides Shasun receives EIR report from USFDAStrides's KRS Gardens facility manufactures oral dosage forms including tablets, capsules (both hard and soft gelatine).
- USFDA continues nod for Strides Bengaluru oral dosage facilityThe inspection was carried out in August 2014, it added. "The oral dosage facility in Bangalore manufactures oral dosage forms such as tabl...
- Strides Arcolab gets USFDA approval for Bangalore facilityThe last USFDA inspection and approval for this facility was in the year 2011, it added.
- Jubilant Life to consolidate pharma business under Singapore unitThe company's board has approved a proposal to transfer its active pharmaceutical ingredient and dosage form business to its Singapore-base...
- Arvind Remedies Q4 net profit at Rs 12.41 croreThe company's net sales for the quarter stood at Rs 173.98 crore, registering a growth of 65 per cent, as against Rs 105.6 crore in year-ag...
Load More
